These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 21978222)

  • 21. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy.
    Paleologou KE; Irvine GB; El-Agnaf OM
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1106-10. PubMed ID: 16246056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane interactions and fibrillization of α-synuclein play an essential role in membrane disruption.
    Chaudhary H; Stefanovic AN; Subramaniam V; Claessens MM
    FEBS Lett; 2014 Nov; 588(23):4457-63. PubMed ID: 25448986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helical alpha-synuclein forms highly conductive ion channels.
    Zakharov SD; Hulleman JD; Dutseva EA; Antonenko YN; Rochet JC; Cramer WA
    Biochemistry; 2007 Dec; 46(50):14369-79. PubMed ID: 18031063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein.
    Smith DP; Tew DJ; Hill AF; Bottomley SP; Masters CL; Barnham KJ; Cappai R
    Biochemistry; 2008 Feb; 47(5):1425-34. PubMed ID: 18179253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains.
    Stöckl M; Fischer P; Wanker E; Herrmann A
    J Mol Biol; 2008 Feb; 375(5):1394-404. PubMed ID: 18082181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure.
    Celej MS; Sarroukh R; Goormaghtigh E; Fidelio GD; Ruysschaert JM; Raussens V
    Biochem J; 2012 May; 443(3):719-26. PubMed ID: 22316405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity.
    Wang X; Moualla D; Wright JA; Brown DR
    J Neurochem; 2010 May; 113(3):704-14. PubMed ID: 20141569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
    Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
    Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic measurements give new insights into lipid membrane permeabilization by α-synuclein oligomers.
    Stöckl M; Claessens MM; Subramaniam V
    Mol Biosyst; 2012 Jan; 8(1):338-45. PubMed ID: 22009045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the regional effects of alpha-synuclein on the organization and stability of phospholipid bilayers.
    Madine J; Doig AJ; Middleton DA
    Biochemistry; 2006 May; 45(18):5783-92. PubMed ID: 16669622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein.
    Roberti MJ; Bertoncini CW; Klement R; Jares-Erijman EA; Jovin TM
    Nat Methods; 2007 Apr; 4(4):345-51. PubMed ID: 17351621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence studies suggest a role for alpha-synuclein in the phosphatidylinositol lipid signaling pathway.
    Narayanan V; Guo Y; Scarlata S
    Biochemistry; 2005 Jan; 44(2):462-70. PubMed ID: 15641770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The alpha-synuclein mutation E46K promotes aggregation in cultured cells.
    Pandey N; Schmidt RE; Galvin JE
    Exp Neurol; 2006 Feb; 197(2):515-20. PubMed ID: 16325180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study.
    Bharathi ; Indi SS; Rao KS
    Neurosci Lett; 2007 Sep; 424(2):78-82. PubMed ID: 17714865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein.
    Thirunavukkuarasu S; Jares-Erijman EA; Jovin TM
    J Mol Biol; 2008 May; 378(5):1064-73. PubMed ID: 18433772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
    Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
    J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA; Harper JD; Lansbury PT
    Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton.
    Esposito A; Dohm CP; Kermer P; Bähr M; Wouters FS
    Neurobiol Dis; 2007 Jun; 26(3):521-31. PubMed ID: 17408955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.